期刊文献+

谷胱甘肽、表面活性剂共存体系对青蒿素过氧键稳定性的影响 被引量:2

Influence of Peroxy Bond′s Stability of Artemisinin in the Presence of Glutathione and Surfactant
下载PDF
导出
摘要 青蒿素的过氧桥键是其抗疟作用的关键部位。采用循环伏安法研究了谷胱甘肽、表面活性剂共存体系对青蒿素过氧键稳定性的影响。实验表明,当青蒿素浓度为1.0mmol/L,谷胱甘肽浓度≥2.0×10-5mol/L时,加入阳离子表面活性剂(1.0×10-5mol/L,DBDAB),在体系中形成了谷胱甘肽-青蒿素-DBDAB三元加合物,该加合物在-0.88V电位下还原,其还原峰电位比游离青蒿素的还原峰电位负移了240mV,其还原反应活化能升高了46·3kJ/moL,使青蒿素的过氧键更趋稳定;而阴离子表面活性剂对体系没有影响。进一步探讨了该三元加合物形成的电极机理。 The characteristic endoperoxide bridge in the artemisinin plays an important role in the antimalarial action. The eyelie voltammetrie experiments were used to study the influence of peroxy bond's stability in artemisinin in the presence of glutathione (GSH) and suffaetant. The eyelie voltammetry experiments indicated that when the concentration of artemisinin was 1.0×10^-3 mol/L, CCSH≥2.0×10^-5 mol/L, adding the cationic surfaetant dodeeyl dimethyl benzylamine (DBDAB, 1.0 ×10^-5 moL/L), the tri-adduet of Glutathione-artemisinin-DBDAB were formed in the ternary system. This tri-adduet reduced at the potential of -0.88 V and its potential shifted 240 mV toward the negative direction compared with that of the free artemisinin. The activation energy is 46.3 kJ/moL higher than that of free artemisinin. So the peroxy bond of artemisinin is more steady. But the anionic suffaetant couldn't form the tri-adducts with artermisinin and glutathione. The mechanisms of the tri-adduets formed at the surface of the electrode were discussed.
出处 《分析化学》 SCIE EI CAS CSCD 北大核心 2006年第3期367-370,共4页 Chinese Journal of Analytical Chemistry
基金 广东省自然科学基金(NO.021190) 广州市科技计划项目(NO.2003Z3-D2041)资助
关键词 青蒿素 谷胱甘肽 表面活性剂 循环伏安法 Artemisinin, glutathione, surfactant, cyclic voltammetry
  • 相关文献

参考文献9

  • 1Wu Y K.Acc.Chem.Res.,2002,35:255~259.
  • 2O'neill P M,Posner G H.J.Med.Chem.,2004,47:2945~2964.
  • 3Shukla K L,Gund T M,Meshnick S R.J.Mol.Graph.,1995,13(4):215~222.
  • 4Wang D Y,Wu Y L.Chem.Commun.,2000:2193~2194.
  • 5Kayser O,Olbrich C,Croft S L,Kiderlen A F.Parasitol Res.90 Suppl.,2003,2:S63~S70.
  • 6Lawrence M J.Chem.Soc.Rev.,1994:417~424.
  • 7周志军,杨培慧,冯德雄,朱宇同,张美义.青蒿素在银电极上的电化学行为及其定量分析[J].分析试验室,2004,23(3):28-30. 被引量:4
  • 8杨培慧,陈晓翔,周志军.青蒿素与还原型谷胱甘肽相互作用的研究[J].药物分析杂志,2005,25(11):1353-1356. 被引量:3
  • 9Meshnick S R,Taylor T E,Kamchonwongpaisan S.Microbiol.Rev.,1996,60(2):301~315.

二级参考文献8

  • 1Richard K Haynes,Hendry Hung-On Pai,Amd Voerste. Ring opening of artemisinin (Qinghaosu) and dihydroartemisin and interception of the open hydroperoxides with formation of N - oxides - a chemical model for antimalarial mode of action. Tetrahedron Lea, 1999, 40(25) :4715.
  • 2Shulda KL, Gund TM, Meshnick SR. Molecular modeling studies of the artemisinin (Qinghaosu) - heroin interaction:Docking between the antimalarial agent and its putative receptor, J Mol Graph, 1995,13(4) :215.
  • 3Wang DY,Wu YL. A possible antimalarial action mode of qinghaosu (artemis'min) series compounds. Alkylation of reduced glutathione by C - centered primary radicals 12 - ( 2,4 - dimethoxyphenyl ) - 12 -deoxoqinghaosu. Chem Commun,2000 ,22 :2193.
  • 4.ChP(中国药典).VolⅡ(二部)[M].,2000.352.
  • 5Meshnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endopemxides: From herbal remedy to targeted chemotherapy. Microbiol Rev, 1996,60(2) :301.
  • 6陈耀祖,张惠迪,张所明,杨清华.藏药短穗兔耳草化学成分的研究[J].高等学校化学学报,1989,10(3):260-262. 被引量:24
  • 7陈扬,朱世民,陈洪渊.青蒿素及其衍生物电化学性质的研究——Ⅱ.青蒿素在氯化血红素存在下的还原[J].化学学报,1998,56(9):925-929. 被引量:7
  • 8吴文敏,伍贻康.青蒿素抗疟机理研究最近的重要进展[J].化学进展,1999,11(3):333-335. 被引量:3

共引文献5

同被引文献22

  • 1杨培慧,郑志雯,周志军,蔡继业.青蒿素在银电极和玻碳电极上的伏安法测定[J].药物分析杂志,2004,24(5):512-515. 被引量:11
  • 2杨培慧,陈晓翔,周志军.青蒿素与还原型谷胱甘肽相互作用的研究[J].药物分析杂志,2005,25(11):1353-1356. 被引量:3
  • 3秦晓蓉,张铭金,伍林,易德莲,魏飞.转铁蛋白的制备方法及其应用前景[J].化学与生物工程,2006,23(10):55-57. 被引量:2
  • 4Wu H, White C C, Isanhart J P, McBride T J, Kavanagh T J, Hooper M J. Ecotoxicology and Environmental Safety, 2009, 72(2) : 572 -578.
  • 5Zhang S, Sun Wen L,Xian Y Z, Zhang W, Jin L T, Yamamoto K, Tao S G, Jin J Y. Anal. Chim. Acta, 1999, 399 (3) : 213 - 221.
  • 6Kafi A K M, Yin F, Shin H K, Kwon Y S. Current Applied Physics, 2007, 7 (5) : 496 -499.
  • 7Lima P R, Santos W J R, Oliveira A B, Goulart M 0 F, Kubota L T. Journal of Pharmaceutical and Biomedical Analysis, 2008, 47(4-5) : 758 -764.
  • 8Zhou M, Ding J, Guo L P, Shang Q K. Anal. Chem. , 2007, 79(14) : 5328 -5335.
  • 9Cao X N, Lin L, Zhou Y Y, Shi GY, Zhang W, Yamamoto K, Jin L T. Talanta, 2003, 60(5) : 1063 -1070.
  • 10Riccia F, Arduini F, Tuta C S, Sozzo U, Mosconea D, Amineb A, Palleschi G. Anal. Chim. Acta, 2006, 558 (1-2): 164 - 170.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部